Literature DB >> 7834749

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

T Miyashita1, J C Reed.   

Abstract

The bax gene promoter region contains four motifs with homology to consensus p53-binding sites. In cotransfection assays using p53-deficient tumor cell lines, wild-type but not mutant p53 expression plasmids transactivated a reporter gene plasmid that utilized the bax gene promoter to drive transcription of chloramphenicol acetyltransferase. In addition, wild-type p53 transactivated reporter gene constructs containing a heterologous minimal promoter and a 39-bp region from the bax gene promoter in which the p53-binding site consensus sequences reside. Introduction of mutations into the consensus p53-binding site sequences abolished p53 responsiveness of reporter gene plasmids. Wild-type but not mutant p53 protein bound to oligonucleotides corresponding to this region of the bax promoter, based on gel retardation assays. Taken together, the results suggest that bax is a p53 primary-response gene, presumably involved in a p53-regulated pathway for induction of apoptosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7834749     DOI: 10.1016/0092-8674(95)90412-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  925 in total

1.  Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization.

Authors:  F Romero; C Martínez-A; J Camonis; A Rebollo
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Different responses of epidermal and hair follicular cells to radiation correlate with distinct patterns of p53 and p21 induction.

Authors:  S Song; P F Lambert
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

3.  Choosing anticancer drug targets in the postgenomic era.

Authors:  W G Kaelin
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

4.  p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades.

Authors:  L Fang; G Li; G Liu; S W Lee; S A Aaronson
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

Review 5.  p53 and cancer therapy: a double-edged sword.

Authors:  G McGill; D E Fisher
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

6.  The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest.

Authors:  S Wang; M Guo; H Ouyang; X Li; C Cordon-Cardo; A Kurimasa; D J Chen; Z Fuks; C C Ling; G C Li
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 7.  A portrait of the Bcl-2 protein family: life, death, and the whole picture.

Authors:  M Pellegrini; A Strasser
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

Review 8.  Regulation of p53 and its targets during involution of the mammary gland.

Authors:  D J Jerry; J Pinkas; C Kuperwasser; E S Dickinson; S P Naber
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

Review 9.  Apoptosis in the estrous and menstrual cycles.

Authors:  A C Andres; R Strange
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

10.  PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.

Authors:  M Tan; Y Wang; K Guan; Y Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.